Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate in TURP bleeding pilot study
IRCT201305097457N13Phase 3Completed
- Sponsor
- Urology-Nephrology Research Center
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fibrinogen human in benign prostatic hyperplasia (BPH), sponsored by Urology-Nephrology Research Center. Started May 2014; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT201305097457N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201305097457N13.